ICOS CORPORATION
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in the commercialization of treatments for unmet medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. It is the developer of a treatment known as Cialis (tadalafil), a product for the treatment of erectile dysfunction through its joint venture with Eli Lilly and C... ompany in North America and Europe. It is also engaged in contract manufacturing services for third parties. It is in a strategic alliance with Solvay Pharmaceuticals, Inc. ICOS Corporation was established in 1989, based in Bothell, Washington. It is currently operated by Eli Lilly and Company.
ICOS CORPORATION
Industry:
Biotechnology Health Care
Founded:
1989-01-01
Status:
Active
Total Funding:
0
Similar Organizations
TransTech Pharma
TransTech Pharma is engaged in the discovery, development, and commercialization of human therapeutics.
Investors List
CHL Medical Partners
CHL Medical Partners investment in Venture Round - ICOS Corporation
More informations about "ICOS Corporation"
ICOS Corporation - Crunchbase Company Profile
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in …See details»
ICOS Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ICOS Corp. with its drug pipeline, therapeutic area, technology platform, 26 clinical trials, 5 news, and 440 literature, Disease Domain:Neoplasms, Technology Platform:Chemical …See details»
ICOS Company Profile 2024: Valuation, Investors, Acquisition
When was ICOS founded? ICOS was founded in 1989. Where is ICOS headquartered? ICOS is headquartered in Bothell, WA. What is the size of ICOS? ICOS has 700 total employees. What …See details»
Lilly Unveils Ambitious Partnership for Tuberculosis Drug Discovery
Jun 12, 2007 After acquiring ICOS Corporation (ICOS) earlier this year, Lilly officials met with ICOS researchers who wanted to apply their experience to discovering drugs for neglected …See details»
Lilly Announces Acquisition of ICOS Corporation - Eli Lilly and …
Announced that it has signed a definitive merger agreement to acquire ICOS Corporation (Nasdaq: ICOS), based in Bothell, Washington, in a cash transaction. Under the terms of the …See details»
ICOS Corporation - Products, Competitors, Financials, Employees ...
ICOS Corporation. Frequently Asked Questions (FAQ) When was ICOS Corporation founded? ICOS Corporation was founded in 1989. Where is ICOS Corporation's headquarters? ICOS …See details»
ICOS Corporation - Funding, Financials, Valuation & Investors
Dec 31, 1990 ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. Search Crunchbase. ... How …See details»
ICOS Corporation Company Profile | Bothell, WA | Competitors ...
Find company research, competitor information, contact details & financial data for ICOS Corporation of Bothell, WA. Get the latest business insights from Dun & Bradstreet.See details»
Icos Corp. - BioCentury Company Profiles - BCIQ
Oct 3, 2019 Icos Corp. - BioCentury Company Profiles for the biopharma industrySee details»
Press release issued by ICOS Corporation - SEC.gov
ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is marketing its …See details»
ICOS CORPORATION OF AMERICA :: New York (US) :: …
Free and open company data on New York (US) company ICOS CORPORATION OF AMERICA (company number 1031295), 4 WEST 58TH ST., NEW YORK, NY, 10019 Learn how to …See details»
Lilly acquires ICOS Corporation for $2.1 Billion - chemeurope.com
Oct 19, 2006 Eli Lilly and Company announced that it has signed a definitive merger agreement to acquire ICOS Corporation in a cash transaction. Under the terms of the agreement, Lilly will …See details»
Paul Clark - Member of the Board of Directors - Crunchbase
Paul was Director, CEO and President of ICOS Corporation from 1999 until the sale to Eli Lilly and Company in 2007. He also served as Chairman from 2000 until 2007. ... Clark led the …See details»
Icos Corp : ICOS Corporation Announces Agreement to be …
Oct 17, 2006 About ICOS Corporation: ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to …See details»
ICOS Corporation Careers and Employment | Indeed.com
May 21, 2012 Find out what works well at ICOS Corporation from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
ICOS Corporation - Tech Stack, Apps, Patents & Trademarks
Organization. ICOS Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
ICOS SWEDEN Operational Plan
Research Infrastructure Consortium), a legal entity for ICOS data release, coordination, and integration of the whole system. A full description of the ICOS RI organization is included in …See details»
ICOs can work for companies, Bank of Canada paper finds
May 9, 2019 Investment Executive | James Langton | May 7, 2019 Initial coin offerings (ICOs) can be an effective approach to start-up financing, argues a paper from the Bank of Canada. A …See details»
ICOS Corporation - Crunchbase
Companies like ICOS Corporation include TransTech Pharma, Roche Glycart, and TCD Pharma. TransTech Pharma High Point , North Carolina , United States 51-100 employeesSee details»